IV Sildenafil Persistent Pulmonary Hypertension Of The Newborn

NCT01360671 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Persistent Pulmonary Hypertension of the Newborn

Interventions

DRUG: Sildenafil

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.